Patents by Inventor Scott Baumgartner

Scott Baumgartner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A COMBINATION OF COLCHICINE AND A CXCR-2 INHIBITORS FOR THE TREATMENT OR PREVENTION OF FAMILIAL MEDITERRANEAN FEVER (FMF) AND FLARE-UPS THEREOF
    Publication number: 20230210792
    Abstract: The present invention relates to the treatment or prevention of Familial Mediterranean Fever (FMF) and flare-ups thereof comprising administering to the subject a combination of (i) colchicine, or a pharmaceutically acceptable salt thereof; and (ii) a CXCR-2 inhibitor, or a pharmaceutically acceptable salt thereof. The preferred CXCR-2 inhibitor N-(6-(((2R,3S)-3,4-dihydroxy butan-2-yl)oxy)-2-((4-fluorobenzyl)thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide.
    Type: Application
    Filed: June 1, 2021
    Publication date: July 6, 2023
    Inventors: Scott BAUMGARTNER, Nihar BHAKTA
  • USE OF IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
    Publication number: 20120308566
    Abstract: The present invention relates to IL-17 Receptor A (IL-17RA or IL-17R) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for treating diseases, such as various forms of cancer.
    Type: Application
    Filed: October 12, 2010
    Publication date: December 6, 2012
    Inventors: David Andrew Martin, Joel Tocker, Scott Baumgartner, Donna Christine Franko